BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 34981693)

  • 21. Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial.
    Horrow JC; Li W; Blobner M; Lombard J; Speek M; DeAngelis M; Herring WJ
    BMC Anesthesiol; 2021 Feb; 21(1):62. PubMed ID: 33639839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of neuromuscular blockade and reversal using cisatricurium and neostigmine with rocuronium and sugamadex on the quality of recovery from general anaesthesia for percutaneous closure of left atria appendage.
    Li Q; Yao H; Wu J; Xu M; Xie H; Wu D
    J Cardiothorac Surg; 2022 Aug; 17(1):211. PubMed ID: 36028870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized-controlled trial of sugammadex versus neostigmine: impact on early postoperative strength.
    Abola RE; Romeiser J; Rizwan S; Lung B; Gupta R; Bennett-Guerrero E
    Can J Anaesth; 2020 Aug; 67(8):959-969. PubMed ID: 32405975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients.
    Woo T; Kim KS; Shim YH; Kim MK; Yoon SM; Lim YJ; Yang HS; Phiri P; Chon JY
    Korean J Anesthesiol; 2013 Dec; 65(6):501-7. PubMed ID: 24427455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative reversal of neuromuscular block with sugammadex or neostigmine during extreme lateral interbody fusion, a novel technique for spine surgery.
    Adamus M; Hrabalek L; Wanek T; Gabrhelik T; Zapletalova J
    J Anesth; 2011 Oct; 25(5):716-20. PubMed ID: 21842171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center.
    Fiorda Diaz J; Echeverria-Villalobos M; Esparza Gutierrez A; Dada O; Stoicea N; Ackermann W; Abdel-Rasoul M; Heard J; Uribe A; Bergese SD
    Front Med (Lausanne); 2022; 9():1072711. PubMed ID: 36569123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of sugammadex in accelerating postoperative discharge: A meta-analysis.
    Carron M; Zarantonello F; Lazzarotto N; Tellaroli P; Ori C
    J Clin Anesth; 2017 Jun; 39():38-44. PubMed ID: 28494905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.
    Jiang Y; Bash LD; Saager L
    Adv Ther; 2021 May; 38(5):2689-2708. PubMed ID: 33871823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
    Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
    Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of sugammadex and pyridostigmine bromide for reversal of rocuronium-induced neuromuscular blockade in short-term pediatric surgery: A prospective randomized study.
    An J; Lee JH; Kim E; Woo K; Kim H; Lee D
    Medicine (Baltimore); 2020 Feb; 99(7):e19130. PubMed ID: 32049831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.
    Della Rocca G; Pompei L; Pagan DE Paganis C; Tesoro S; Mendola C; Boninsegni P; Tempia A; Manstretta S; Zamidei L; Gratarola A; Murabito P; Fuggiano L; DI Marco P
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1138-45. PubMed ID: 23849107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sugammadex Versus Neostigmine for Neuromuscular Block Reversal and Postoperative Pulmonary Complications in Patients Undergoing Resection of Lung Cancer.
    Yu Y; Wang H; Bao Q; Zhang T; Chen B; Ding J
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3626-3633. PubMed ID: 35662514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.
    Schepens T; Janssens K; Maes S; Wildemeersch D; Vellinga J; Jorens PG; Saldien V
    BMC Anesthesiol; 2019 Oct; 19(1):187. PubMed ID: 31629404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of reversal with neostigmine of low-dose rocuronium vs. reversal with sugammadex of high-dose rocuronium for a short procedure.
    Choi ES; Oh AY; Koo BW; Hwang JW; Han JW; Seo KS; Ahn SH; Jeong WJ
    Anaesthesia; 2017 Oct; 72(10):1185-1190. PubMed ID: 28493510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade.
    Kim KS; Oh YN; Kim TY; Oh SY; Sin YH
    Korean J Anesthesiol; 2016 Jun; 69(3):239-43. PubMed ID: 27274368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade.
    Goodner JA; Likar EJ; Hoff AL; Quedado JM; Kohli A; Ellison P
    Cureus; 2021 Jun; 13(6):e15413. PubMed ID: 34249560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Residual neuromuscular blockade in a real life clinical setting: correlation with sugammadex or neostigmine administration.
    Batistaki C; Tentes P; Deligiannidi P; Karakosta A; Florou P; Kostopanagiotou G
    Minerva Anestesiol; 2016 May; 82(5):550-8. PubMed ID: 26394365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.